{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:01:36Z","timestamp":1761058896177},"reference-count":91,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T00:00:00Z","timestamp":1233619200000},"content-version":"vor","delay-in-days":3992,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Cardiology"],"published-print":{"date-parts":[[1998,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Postmyocardial infarction (MI) survival has been steadily improving. This improvement has been due, in part, to the actions of the adjunctive medical therapies for the treatment of MI. Aspirin, beta blockers, angiotensin\u2010converting enzyme (ACE) inhibitors, and lipid\u2010lowering agents have been shown to improve survival in the treatment and secondary prevention of MI. Nitrates have beneficial effects as well. These medications complement the reperfusion strategies through different mechanisms. Other adjunctive medical therapies, namely magnesium, antiarrhythmic agents, and calcium\u2010channel blockers, have not been shown to improve mortality with routine post\u2010MI use despite their theoretical benefits.<\/jats:p>","DOI":"10.1002\/clc.4960210305","type":"journal-article","created":{"date-parts":[[2009,2,4]],"date-time":"2009-02-04T02:02:33Z","timestamp":1233712953000},"page":"161-168","source":"Crossref","is-referenced-by-count":9,"title":["Pathophysiologic bases for adjunctive therapies in the treatment and secondary prevention of acute myocardial infarction"],"prefix":"10.1002","volume":"21","author":[{"given":"David E.","family":"Gutstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,2,3]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.87.6.1947"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90367-0"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(96)90349-X"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.1.574"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90136-8"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/oxfordjournals.eurheartj.a060379","article-title":"Declining hospital mortality in acute myocardial infarction","volume":"15","author":"Dellborg M","year":"1994","journal-title":"Eur Heart J"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-199412000-00007"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.2.342"},{"key":"e_1_2_1_10_2","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS\u20102","volume":"2","author":"ISIS (Second International Study of Infarct Survival) Collaborative Group","year":"1988","journal-title":"Lancet"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0733-8651(18)30506-X","article-title":"Thrombolysis in acute myocardial infarction","volume":"6","author":"Chesebro JH","year":"1988","journal-title":"Cardiol Clin"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91538-W"},{"key":"e_1_2_1_13_2","first-page":"III\u20101","article-title":"Antithrombotic therapy for acute myocardial infarction: Mechanisms and prevention of deep venous, left ventricular and coronary artery thromboembolism","volume":"74","author":"Chesebro JH","year":"1986","journal-title":"Circulation"},{"key":"e_1_2_1_14_2","first-page":"II\u2010117","article-title":"Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials","volume":"82","author":"Yusuf S","year":"1990","journal-title":"Circulation"},{"key":"e_1_2_1_15_2","first-page":"921","article-title":"Mechanisms for the early mortality reduction produced by beta blockade started early in acute myocardial infarction: ISIS\u20101","volume":"1","author":"ISIS\u20101 (First International Study of Infarct Survival) Collaborative Group","year":"1988","journal-title":"Lancet"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90316-6"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2010I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"Br Med J"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199207233270406"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470693926.ch15"},{"key":"e_1_2_1_20_2","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610033351401"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.87.6.1781"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201303260506"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(94)90178-3"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.64.6.319"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00411-0"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(89)90409-9"},{"key":"e_1_2_1_28_2","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure","volume":"342","author":"The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","year":"1993","journal-title":"Lancet"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199501123320203"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209033271001"},{"key":"e_1_2_1_31_2","first-page":"1115","article-title":"GISSI\u20103: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6\u2010week mortality and ventricular function after acute myocardial infarction","volume":"343","author":"Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico","year":"1994","journal-title":"Lancet"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.78.4.906"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1001\/jama.1988.03410130118036","article-title":"Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials","volume":"260","author":"MacMahon S","year":"1988","journal-title":"J Am Med Assoc"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198908103210629"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199207233270403"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a060043"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.4_Supplement.247S"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00392-0"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703203361207"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(88)92644-7"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.4_Supplement.258S"},{"key":"e_1_2_1_42_2","first-page":"65","article-title":"GISSI\u20102: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction","volume":"336","author":"Gruppo Italiano per lo Studio Della Sopravvivenza nell'Infarto Miocardico","year":"1990","journal-title":"Lancet"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91590-7"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91893-D"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309023291001"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199007193230302"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)92154-6"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198209163071201"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)01180-X"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90125-V"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.5.911"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199609123351103"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708143370702"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91270-2"},{"key":"e_1_2_1_55_2","first-page":"57","article-title":"Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS\u20101","volume":"2","author":"ISIS\u20101 (First International Study of Infarct Survival) Collaborative Group","year":"1986","journal-title":"Lancet"},{"key":"e_1_2_1_56_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/oxfordjournals.eurheartj.a061845","article-title":"Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo\u2010controlled international trial","volume":"6","author":"The MIAMI Trial Research Group","year":"1985","journal-title":"Eur Heart J"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(85)90691-5"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198903093201002"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199611283352207"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706043162301"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a015063"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00605-2"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.4.1731"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512213332503"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209033271002"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00285-8"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90865-X"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1988.00380010040006"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511163332001"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)00318-X"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960190903"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91906-X"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00498-X"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(96)90339-7"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91828-V"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92024-9"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/0033-0620(93)90008-2"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.70.5.960"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.86.3.774"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.303.6816.1499"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80546-3"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)02149-6"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.88.2.764"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.153.23.2661"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09145-3"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)08171-8"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/16.suppl_H.19"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80441-X"},{"key":"e_1_2_1_89_2","first-page":"V\u2010148","article-title":"Secondary prevention with calcium channel\u2010blocking drugs in patients after myocardial infarction: A critical review","volume":"75","author":"Moss AJ","year":"1987","journal-title":"Circulation"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.299.6709.1187"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198808183190701"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(90)90351-Z"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.4960210305","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clc.4960210305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T17:52:19Z","timestamp":1698515539000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.4960210305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["10.1002\/clc.4960210305"],"URL":"https:\/\/doi.org\/10.1002\/clc.4960210305","archive":["Portico"],"relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}